Spirometry Test for Asthma: What FEV1, FVC & Your Results Really Mean

What Is Spirometry?

Spirometry (from the Latin spiro, "to breathe") is a pulmonary function test that records air volume and flow as you exhale forcefully into a spirometer. The device plots a flow-volume loop and a volume-time curve, generating several derived measurements. It is standardized by the American Thoracic Society (ATS) and European Respiratory Society (ERS) and requires at least three technically acceptable maneuvers to be considered valid.

Spirometry differs from a simple peak flow meter in precision and scope. A peak flow meter measures only peak expiratory flow rate (PEFR) -- a single data point useful for at-home asthma monitoring. Spirometry generates a full curve with multiple parameters and is far more sensitive for detecting mild or variable obstruction.

In Broward County's warm, high-humidity climate, airway inflammation can fluctuate with seasonal allergens (tree pollen in spring, ragweed in fall), mold spores, and year-round dust mite activity. Spirometry captures this variability when performed on the right day -- or, crucially, on a symptomatic day.

What Spirometry Measures: Key Values Explained

Every spirometry report includes several values. Here are the ones that matter most for asthma:

Your report will also show each value as a percentage of the predicted value -- what a healthy person of your age, sex, height, and ethnicity would be expected to achieve. The Global Lung Function Initiative (GLI-2012) equations are the current preferred reference standard, replacing the older NHANES III equations for most populations.

How the Spirometry Test Works: Step by Step

The test is brief, typically 15-30 minutes for a baseline assessment or up to 45 minutes when post-bronchodilator measurements are included.

1. Check-in and preparation: Height and weight are measured (needed to calculate predicted values). You will be asked about recent bronchodilator use, smoking, respiratory infections, and recent surgery.
2. Positioning: You sit upright in a chair. A nose clip is placed to prevent air escaping through your nose.
3. Maximal inhalation: You inhale as deeply as possible until your lungs are completely full.
4. Forced exhalation: You then blow out as hard, fast, and long as possible -- at least six seconds, ideally until the curve plateaus. The technician will coach you verbally throughout.
5. Repetition: The maneuver is repeated at least three times. The two best results must agree within 150 mL of each other (ATS/ERS 2019 criteria) for the test to be considered reproducible.
6. Bronchodilator step (if ordered): You inhale albuterol 400 mcg via spacer and wait 15 minutes. Spirometry is then repeated to assess reversibility.

The test is safe for the vast majority of patients. Contraindications include recent MI (within 3 months), recent thoracic or abdominal surgery, unstable angina, or aortic aneurysm. Active respiratory infection is also a reason to defer testing.

Interpreting Spirometry Results: The Obstruction Pattern

Asthma produces an obstructive ventilatory defect. The obstructive pattern is defined by an FEV1/FVC ratio below the lower limit of normal, with FVC often normal or mildly reduced. This is in contrast to a restrictive defect (low FVC, preserved or elevated FEV1/FVC), which is seen in pulmonary fibrosis, severe obesity, or neuromuscular disease.

An important limitation: spirometry can be completely normal between asthma episodes, especially in patients with mild or intermittent asthma. A normal result does not rule out asthma. If your spirometry is normal but symptoms persist, the next step is typically a methacholine challenge test to directly measure airway hyperresponsiveness.

Bronchodilator Reversibility: The Key to Confirming Asthma

The bronchodilator reversibility test is performed by administering albuterol 400 mcg and repeating spirometry 15 minutes later. In asthma, airway narrowing results from smooth muscle contraction and mucosal edema that respond rapidly to bronchodilators. In COPD, much of the obstruction is structural and fixed.

A positive reversibility result (ATS/ERS criteria) requires both:

• FEV1 increases by 12% or more from baseline, AND
• FEV1 increases by an absolute value of 200 mL or more

Both criteria must be met simultaneously. A positive result in the right clinical context confirms asthma and typically eliminates the need for further provocation testing. Some patients show reversibility in FVC rather than FEV1 -- this pattern reflects air trapping that resolves with bronchodilation and is also clinically significant.

A negative reversibility test does not exclude asthma. Airway obstruction in asthma is variable; if airways are open on the test day (for example, if the patient recently used an inhaler, or is in a period of low allergen exposure), the test may not capture obstruction. This is why serial testing or methacholine challenge testing may be needed to confirm the diagnosis.

Asthma Severity Classification Using Spirometry

Once asthma is diagnosed, FEV1 percent predicted helps classify severity according to NAEPP and GINA guidelines. This classification directly guides step-up therapy decisions, including referral for biologic treatment.

FDA-approved biologic medications for asthma -- including mepolizumab (Nucala), benralizumab (Fasenra), dupilumab (Dupixent), and tezepelumab (Tezspire) -- each include an asthma severity or FEV1 threshold in their FDA-approved indications. Serial spirometry is therefore essential both for biologic eligibility documentation and for monitoring treatment response after initiation.

How Often Should Asthma Patients Have Spirometry?

GINA and NAEPP guidelines recommend spirometry:

• At diagnosis -- baseline measurement before starting controller therapy
• 3-6 months after initiating or changing therapy -- to document treatment response
• Annually at minimum -- for ongoing severity assessment and to detect gradual lung function decline
• During or shortly after an exacerbation -- to confirm recovery to the patient's personal best
• Before biologic initiation and at 6-12 month intervals thereafter -- to document efficacy and justify continuation

In South Florida's warm climate with year-round allergen exposure, chronic subclinical airway inflammation is common even in patients who feel well on controller therapy. Annual spirometry catches the small number of patients experiencing progressive lung function decline before it becomes symptomatic -- a finding that should trigger a step-up in therapy or biologic evaluation.

Spirometry vs. Peak Flow Meter: Which Do You Need?

The two tools are complementary. Spirometry establishes the diagnosis and classifies severity; a peak flow meter at home monitors day-to-day variability as part of your asthma action plan. Persistent peak flow readings below 80% of your personal best on three or more consecutive days are an indication to call your physician and schedule spirometry.

How to Prepare for a Spirometry Test

To obtain the most accurate results, follow these preparation steps before your appointment:

Unlike the methacholine challenge test, standard spirometry does not require withholding caffeine. However, if a combined spirometry-methacholine protocol has been ordered, the stricter methacholine preparation guidelines apply. Always confirm the specific preparation instructions with your clinic when scheduling.

When Spirometry Alone Is Not Enough

Spirometry captures airway function at a single point in time. In asthma -- defined by variable airflow obstruction -- that snapshot may be completely normal. Consider these additional tests when spirometry is insufficient:

• Normal spirometry with persistent symptoms: Proceed to methacholine challenge test. A PC20 of 16 mg/mL or less confirms airway hyperresponsiveness consistent with asthma with 90-99% sensitivity.
• COPD cannot be excluded: DLCO (diffusing capacity), full lung volumes via body plethysmography, and chest CT help distinguish the two conditions and identify asthma-COPD overlap (ACO).
• Small airway disease suspected: Low FEF25-75% with preserved FEV1/FVC may warrant impulse oscillometry (IOS) for peripheral airway resistance measurement.
• Exercise-induced symptoms: Pre- and post-exercise spirometry, or formal exercise challenge testing, identifies exercise-induced bronchoconstriction (EIB).
• Elevated FeNO: Fractional exhaled nitric oxide (FeNO testing) identifies eosinophilic airway inflammation independently of spirometry and improves diagnostic and treatment decisions.

Spirometry for Asthma in Plantation, FL and Broward County

At Advanced Asthma Clinic, Dr. Frank Hull performs spirometry using ATS/ERS-compliant equipment with experienced respiratory technicians. Testing is available for:

• New patients seeking an asthma diagnosis or specialist second opinion
• Established patients needing annual monitoring or pre-biologic eligibility documentation
• Post-exacerbation follow-up to confirm return to personal best baseline
• Patients with persistent symptoms despite current controller therapy

Dr. Hull brings more than 20 years of pulmonary research experience to the interpretation of spirometry results -- accounting for South Florida's unique year-round allergen profile, occupational exposures common in the region's healthcare and construction sectors, and comorbid conditions such as obesity, GERD, and allergic rhinitis that frequently complicate asthma management. The clinic serves patients from Plantation, Fort Lauderdale, Davie, Weston, Miramar, Pembroke Pines, Hollywood, and throughout Broward County.

This content is provided for educational purposes only and does not constitute medical advice. Always consult your physician before changing any medications or treatment plan based on test results.